Bruton’s Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE?

Bruton’s Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE?

Ana Lorenzo-Vizcaya,1 Serena Fasano,2 David A Isenberg3 1Department of Internal Medicine, Hospital Universitario De Ourense, Ourense, Spain; 2Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Campania L. Vanvitelli, Naples, Italy; 3Centre for Rheumatology, Department...

Full description

Bibliographic Details
Main Authors: Lorenzo-Vizcaya A, Fasano S, Isenberg DA
Format: Article
Language:English
Published: Dove Medical Press 2020-06-01
Series:ImmunoTargets and Therapy
Subjects:
lupus
bruton
tyrosine kinase
therapeutic targeting
ibrutinib
fenebrutinib
Online Access:https://www.dovepress.com/brutonrsquos-tyrosine-kinase-inhibitors-a-new-therapeutic-target-for-t-peer-reviewed-article-ITT

Internet

https://www.dovepress.com/brutonrsquos-tyrosine-kinase-inhibitors-a-new-therapeutic-target-for-t-peer-reviewed-article-ITT

Similar Items